Proposed Data Collection Submitted for Public Comment and Recommendations, 53308-53309 [2021-20844]

Download as PDF 53308 Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices 3. For both preventive interventions and diagnostic/treatment services in your workplace, please describe how widely the services are used, how stigma associated with seeking mental health care is addressed, and how health workers are encouraged to participate. In your experience, how does the workplace benefit from implementing interventions or offering services to health workers to prevent/ reduce work-related stress, to decrease stigma related to seeking and receiving care, and to improve the mental health and well-being of health workers? 4. Please describe any programs you are aware of that help employers to fund or otherwise develop interventions or services to support health worker mental health and well-being. Questions About Workplaces 5. Please tell us about your experience with any workplace policies designed to protect workers from stress and adverse mental health outcomes and to address these issues. Describe the part(s) of your organization involved in workassociated stress prevention efforts. lotter on DSK11XQN23PROD with NOTICES1 Questions About Health Workers’ Communication Preferences 6. Please tell us about your workplace’s most effective methods of informing health workers about available interventions, services, and workplace practices and policies, including but not limited to: Notification channels, trusted messengers (e.g., upper management, front line supervisor, union representatives), and efforts to reach workers who are underserved by mental health/behavioral health resources. 7. In your experience, do workers seek mental health and well-being information outside the workplace and, if so, where (e.g., community-based, faith-based)? Do health workers generally find sources of information outside the workplace more trustworthy and credible than employer-based programs? If so, what is the basis for this understanding and what efforts have you undertaken to address such concerns? In addition to the specific questions above, NIOSH would also like to hear from researchers currently conducting research on stress, burnout, and other VerDate Sep<11>2014 18:08 Sep 24, 2021 Jkt 253001 mental health and well-being concerns among a broad range of health workers. John J. Howard, Administrator, World Trade Center Health Program and Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Department of Health and Human Services. [FR Doc. 2021–20931 Filed 9–24–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–21–0210; Docket No. CDC–2021– 0102] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a continuing information collection project titled List of Ingredients Added to Tobacco in the Manufacture of Cigarette Products. The proposed collection allows CDC’s Office of Smoking and Health (OSH) to collect information about the ingredients used in cigarette products, a responsibility that has been delegated to CDC by HHS. DATES: CDC must receive written comments on or before November 26, 2021. SUMMARY: You may submit comments, identified by Docket No. CDC–2021– 0102 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–H21–8, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. ADDRESSES: PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses; and 5. Assess information collection costs. FOR FURTHER INFORMATION CONTACT: Proposed Project List of Ingredients Added to Tobacco in the Manufacture of Cigarette Products (OMB Control No. 0920–0210, Exp. 4/30/2022)—Extension—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), E:\FR\FM\27SEN1.SGM 27SEN1 53309 Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices Centers for Disease Control and Prevention (CDC). Background and Brief Description Cigarette smoking is the leading preventable cause of premature death and disability in our nation. Each year more than 480,000 deaths occur as the result of cigarette smoking-related diseases. The CDC’s Office on Smoking and Health (OSH) is the lead federal agency for comprehensive tobacco prevention and control. Since 1986, as required by the Comprehensive Smoking Education Act (CSEA) of 1984, which amended the Federal Cigarette Labeling and Advertising Act (FCLAA), 15 U.S.C. 1335a, CDC has collected information about the ingredients used in cigarette products. HHS has delegated responsibility for implementing the required information collection to CDC’s OSH. Respondents are commercial cigarette manufacturers, packagers, or importers (or their representatives), who Attention: FCLAA Program Manager, Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS S107–7, Atlanta, GA 30341–3717. Upon receipt and verification of the annual ingredient report, CDC issues a Certificate of Compliance to the respondent. As deemed appropriate by the Secretary of HHS, HHS is authorized to use the information to report to Congress the health effects of ingredients, research activities related to the health effects of ingredients, and other information that the Secretary determines to be of public interest. There are no costs to respondents other than their time. The total estimated annualized burden hours are 358. OMB approval is requested for three years. are required by FCLAA to submit ingredient reports to HHS on an annual basis. Respondents are not required to submit specific forms; however, they are required to submit a list of all ingredients used in their products. CDC requires the ingredient report to be submitted by chemical name and Chemical Abstract Service (CAS) Registration Number, consistent with accepted reporting practices for other companies currently required to report ingredients added to other consumer products. The information collected is subject to strict confidentiality provisions. Ingredient reports are due annually on March 31. Information is submitted to CDC by mailing or faxing a written report on the respondent’s letterhead. All faxed lists should be followed up with a mailed original. Electronic mail submissions are not accepted. Mail Annual Ingredient Submissions to ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Form name Business Entities ............................... N/A ................................................... 55 1 6.5 358 Total ........................................... ........................................................... ........................ ........................ ........................ 358 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2021–20844 Filed 9–24–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–21–0666; Docket No. CDC–2021– 0100] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on SUMMARY: VerDate Sep<11>2014 18:08 Sep 24, 2021 Jkt 253001 a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Healthcare Safety Network (NHSN). NHSN is the nation’s most widely used healthcare-associated infection tracking system, providing facilities, states, regions, and the nation with data needed to identify problem areas, measure progress of prevention efforts, and ultimately eliminate healthcare-associated infections. DATES: CDC must receive written comments on or before November 26, 2021. change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H21–8, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@ cdc.gov. You may submit comments, identified by Docket No. CDC–2020– 0100 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H21–8, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without SUPPLEMENTARY INFORMATION: ADDRESSES: AGENCY: lotter on DSK11XQN23PROD with NOTICES1 Number of respondents Type of respondents PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of E:\FR\FM\27SEN1.SGM 27SEN1

Agencies

[Federal Register Volume 86, Number 184 (Monday, September 27, 2021)]
[Notices]
[Pages 53308-53309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20844]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-21-0210; Docket No. CDC-2021-0102]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a continuing 
information collection project titled List of Ingredients Added to 
Tobacco in the Manufacture of Cigarette Products. The proposed 
collection allows CDC's Office of Smoking and Health (OSH) to collect 
information about the ingredients used in cigarette products, a 
responsibility that has been delegated to CDC by HHS.

DATES: CDC must receive written comments on or before November 26, 
2021.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0102 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.

    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed 
above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    List of Ingredients Added to Tobacco in the Manufacture of 
Cigarette Products (OMB Control No. 0920-0210, Exp. 4/30/2022)--
Extension--National Center for Chronic Disease Prevention and Health 
Promotion (NCCDPHP),

[[Page 53309]]

Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Cigarette smoking is the leading preventable cause of premature 
death and disability in our nation. Each year more than 480,000 deaths 
occur as the result of cigarette smoking-related diseases. The CDC's 
Office on Smoking and Health (OSH) is the lead federal agency for 
comprehensive tobacco prevention and control. Since 1986, as required 
by the Comprehensive Smoking Education Act (CSEA) of 1984, which 
amended the Federal Cigarette Labeling and Advertising Act (FCLAA), 15 
U.S.C. 1335a, CDC has collected information about the ingredients used 
in cigarette products. HHS has delegated responsibility for 
implementing the required information collection to CDC's OSH. 
Respondents are commercial cigarette manufacturers, packagers, or 
importers (or their representatives), who are required by FCLAA to 
submit ingredient reports to HHS on an annual basis.
    Respondents are not required to submit specific forms; however, 
they are required to submit a list of all ingredients used in their 
products. CDC requires the ingredient report to be submitted by 
chemical name and Chemical Abstract Service (CAS) Registration Number, 
consistent with accepted reporting practices for other companies 
currently required to report ingredients added to other consumer 
products. The information collected is subject to strict 
confidentiality provisions.
    Ingredient reports are due annually on March 31. Information is 
submitted to CDC by mailing or faxing a written report on the 
respondent's letterhead. All faxed lists should be followed up with a 
mailed original. Electronic mail submissions are not accepted. Mail 
Annual Ingredient Submissions to Attention: FCLAA Program Manager, 
Office on Smoking and Health, National Center for Chronic Disease 
Prevention and Health Promotion, Centers for Disease Control and 
Prevention, 4770 Buford Highway NE, MS S107-7, Atlanta, GA 30341-3717.
    Upon receipt and verification of the annual ingredient report, CDC 
issues a Certificate of Compliance to the respondent. As deemed 
appropriate by the Secretary of HHS, HHS is authorized to use the 
information to report to Congress the health effects of ingredients, 
research activities related to the health effects of ingredients, and 
other information that the Secretary determines to be of public 
interest.
    There are no costs to respondents other than their time. The total 
estimated annualized burden hours are 358. OMB approval is requested 
for three years.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Business Entities.............  N/A.............              55               1             6.5             358
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             358
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-20844 Filed 9-24-21; 8:45 am]
BILLING CODE 4163-18-P